TNDM Stock Overview
A medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Tandem Diabetes Care, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$32.51 |
52 Week High | US$53.69 |
52 Week Low | US$20.52 |
Beta | 1.37 |
11 Month Change | 1.88% |
3 Month Change | -22.17% |
1 Year Change | 53.20% |
33 Year Change | -75.19% |
5 Year Change | -44.63% |
Change since IPO | -83.12% |
Recent News & Updates
Tandem Diabetes: Recurring Value Erosion, Not Right Point In Cycle To Own
Nov 28Slammed 27% Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Screens Well Here But There Might Be A Catch
Nov 16Health Check: How Prudently Does Tandem Diabetes Care (NASDAQ:TNDM) Use Debt?
Sep 28Potential Upside For Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Not Without Risk
Aug 31Recent updates
Tandem Diabetes: Recurring Value Erosion, Not Right Point In Cycle To Own
Nov 28Slammed 27% Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Screens Well Here But There Might Be A Catch
Nov 16Health Check: How Prudently Does Tandem Diabetes Care (NASDAQ:TNDM) Use Debt?
Sep 28Potential Upside For Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Not Without Risk
Aug 31Tandem Diabetes: Mobi's Surprise Sales Fail To Offset Flat Operating Margin
Aug 14Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Aug 04Is It Time To Consider Buying Tandem Diabetes Care, Inc. (NASDAQ:TNDM)?
Jul 12Is Tandem Diabetes Care (NASDAQ:TNDM) Weighed On By Its Debt Load?
Jun 18Tandem Diabetes Care: Recent Rally Fully Deserved, Likely More Upside Here
May 29Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) 26% Jump Shows Its Popularity With Investors
May 10A Look At The Fair Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
May 04At US$30.10, Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Worth Looking At Closely?
Mar 26Even With A 27% Surge, Cautious Investors Are Not Rewarding Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Performance Completely
Mar 08Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?
Feb 22Estimating The Intrinsic Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Jan 14Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Stock Rockets 63% But Many Are Still Ignoring The Company
Dec 27Is It Too Late To Consider Buying Tandem Diabetes Care, Inc. (NASDAQ:TNDM)?
Nov 12Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Intrinsic Value Is Potentially 53% Above Its Share Price
Oct 06Does Tandem Diabetes Care (NASDAQ:TNDM) Have A Healthy Balance Sheet?
Sep 17Should You Think About Buying Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Now?
Aug 08Calculating The Intrinsic Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Jul 03Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt Sensibly?
Jun 13Cautious Investors Not Rewarding Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Performance Completely
May 06Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?
Jan 04Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Potentially Undervalued?
Oct 15Tandem Diabetes Care: Overpriced, Underdelivering
Sep 22An Intrinsic Calculation For Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Suggests It's 50% Undervalued
Sep 10Tandem Diabetes stock falls 10% on disappointing Q2 result
Aug 03Tandem Diabetes Care acquires Capillary Biomedical; terms undisclosed
Jul 21Tandem Diabetes Care: Strong Financials And Revenue, Overpenalized For Missed Earnings
Jul 08Tandem Diabetes Care (NASDAQ:TNDM) Is Looking To Continue Growing Its Returns On Capital
Jun 20Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Intrinsic Value Is Potentially 43% Above Its Share Price
May 30Shareholder Returns
TNDM | US Medical Equipment | US Market | |
---|---|---|---|
7D | 6.9% | 0.3% | 0.7% |
1Y | 53.2% | 20.5% | 32.2% |
Return vs Industry: TNDM exceeded the US Medical Equipment industry which returned 21% over the past year.
Return vs Market: TNDM exceeded the US Market which returned 31.9% over the past year.
Price Volatility
TNDM volatility | |
---|---|
TNDM Average Weekly Movement | 7.3% |
Medical Equipment Industry Average Movement | 7.7% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.4% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: TNDM has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: TNDM's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 2,400 | John Sheridan | www.tandemdiabetes.com |
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company’s flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body.
Tandem Diabetes Care, Inc. Fundamentals Summary
TNDM fundamental statistics | |
---|---|
Market cap | US$2.01b |
Earnings (TTM) | -US$126.78m |
Revenue (TTM) | US$854.35m |
2.5x
P/S Ratio-16.8x
P/E RatioIs TNDM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TNDM income statement (TTM) | |
---|---|
Revenue | US$854.35m |
Cost of Revenue | US$428.94m |
Gross Profit | US$425.41m |
Other Expenses | US$552.20m |
Earnings | -US$126.78m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.93 |
Gross Margin | 49.79% |
Net Profit Margin | -14.84% |
Debt/Equity Ratio | 146.6% |
How did TNDM perform over the long term?
See historical performance and comparison